Research Priorities to Increase Confidence in and Acceptance of Health Preference Research: What Questions Should be Prioritized Now?

Rachael L. DiSantostefano, Ian P. Smith, Marie Falahee, Aura Cecilia Jiménez-Moreno, Serena Oliveri, Jorien Veldwijk, G. Ardine de Wit, Ellen M. Janssen, Conny Berlin, Catharina G. M. Groothuis-Oudshoorn

Research output: Contribution to JournalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)179-190
JournalThe Patient - Patient-Centered Outcomes Research
Volume17
Issue number2
DOIs
Publication statusPublished - 16 Dec 2023

Funding

This study formed part of the Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) project, which has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 115966. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation program and the European Federation of Pharmaceutical Industries and Associations.

FundersFunder number
Horizon 2020 Framework Programme
European Federation of Pharmaceutical Industries and Associations
Innovative Medicines Initiative115966

    Cite this